Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Hospitalization

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniformed Services University of the Health Sciences

About this trial

This study evaluates the effectiveness of Pathfinding, a 6-month, remotely-delivered case management intervention designed to decrease suicidal behavior among active-duty Regular Army soldiers recently discharged from inpatient psychiatric treatment. Soldiers discharged from military treatment facilities across the U.S. will be identified and recruited to participate. Those who consent will be randomly assigned to receive either Treatment As Usual (TAU), which is the Army's standard post-discharge care, or TAU plus Pathfinding. Participants will complete a baseline assessment and follow-up assessments 6 months and 12 months later. The 6- and 12-month follow-up periods will also include examination of participants' electronic healthcare data and Army administrative data. The overall goals of the study are: (1) to evaluate whether Pathfinding decreases suicidal behaviors among soldiers transitioning from psychiatric hospitalization back to the community; and (2) to determine which discharged soldiers are most likely to benefit from the Pathfinding intervention versus TAU alone.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Active duty Regular Army soldiers recently discharged from inpatient psychiatric care at a military treatment facility in the US

Access to telephone and computer (including smartphone)

Disqualifiers

Impaired ability to provide informed consent

Terminal illness

Failure to complete baseline survey within 30 days of discharge

Positive screen for post-discharge suicide-related behaviors

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pathfinding

    Behavioral

    The Pathfinding intervention consists of remote (videoconference or phone) interactions between participants and masters-level Guides over the 6 months following study enrollment. Participants have the option of involving a support person (SP) in the intervention (e.g., family member, friend). First 4 sessions (45 min. each) occur as soon as possible following hospital discharge and focus on orientation to Pathfinding, identifying a SP, and identifying and prioritizing values/needs, values-consistent goals, corresponding actions, and relevant resources. Participants subsequently receive up to 10 brief (15-30 min. each) contacts to monitor risk and progress. Frequency of contacts is front-loaded and diminishes over time as participants take more control over managing their transition. SPs are contacted for up to 5 sessions (10-15 min. each) to help with monitoring and support. Sessions, risk assessments, and any crisis response actions are documented in the electronic health record.

  • Treatment As Usual (TAU)

    Behavioral

    TAU is standard post-discharge care based on Defense Health Agency policy (DHA Administrative Instruction 6025.06): Discharge plans must consist of referral with plans for outpatient or partial hospitalization follow-up within 7 days (optimally within 72 hours). Discharged patients are placed on a High-Risk (HR) list for at least 30 days. During this period, patients are seen weekly for follow-up appointments or attendance of the HR group if individual psychotherapy is not available. If, after 4 weeks, the patient is assessed as no longer acutely suicidal, they are removed from the HR list. After removal from the HR list, patients are seen either weekly or every other week, depending on clinical need. Initial care coordination is handled by the discharge nurse. Ongoing care coordination is managed by the outpatient mental health team. Safety planning is conducted at discharge and every few sessions thereafter using the DHA safety plan. Safety assessments are conducted at each visit.

Treatment groups

1,500 Participants
are divided into 2 treatment groups
Group A: Pathfinding intervention plus Treatment As Usual (TAU)Experimental treatment 1 intervention
Group B: Treatment As Usual (TAU)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Suicide-related behaviors

Suicide-related behaviors are defined as: suicide death (administratively documented or informant reported), nonfatal suicide attempt (self-reported or administratively documented), and interrupted suicide attempt, aborted suicide attempt, and preparatory behaviors for suicide (the latter 3 are all self-reported).

Time frame
Within the 12 months following completion of the baseline assessment

Secondary outcomes

1

Number of suicide attempts

A count of nonfatal suicide attempts (self-reported or administratively documented) that occurred during the follow-up period.

Time frame
Within the 12 months following completion of the baseline assessment
2

Rehospitalization

Psychiatric hospitalization (self-reported, informant reported, or administratively documented) during the follow-up period.

Time frame
Within the 12 months following completion of the baseline assessment
3

Non-suicide death

Any manner of death other than suicide (informant reported or administratively documented) during the follow-up period.

Time frame
Within the 12 months following completion of the baseline assessment
4

Risky behaviors

Risky behaviors (self-reported) related to driving or riding in a vehicle, sexual encounters, and aggression (bullying, sexual harassment, intimate partner violence) during the follow-up period.

Time frame
Within the 12 months following completion of the baseline assessment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Uniformed Services University of the Health Sciences

Lead sponsor

Harvard Medical School (HMS and HSDM)

Collaborator

University of Michigan

Collaborator